ANNX
Annexon, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +9.1% ·
flujo de acciones -16.9% ·
nuevas posiciones netas +8.3%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | 0 | 98.98M | $564.98M | +7 | −7 |
| Q1 2026 | 86 | +9 | 86.15M | $477.02M | +15 | −6 |
| Q4 2025 | 77 | +3 | 76.53M | $384.12M | +3 | — |
| Q3 2025 | 16 | +1 | 41.50M | $126.59M | +2 | −1 |
| Q2 2025 | 12 | 0 | 37.67M | $90.40M | +2 | −2 |
| Q1 2025 | 9 | -2 | 6.64M | $12.81M | — | −2 |
| Q4 2024 | 11 | -2 | 14.57M | $74.72M | — | −2 |
| Q3 2024 | 12 | +1 | 12.67M | $75.00M | +1 | — |
| Q2 2024 | 11 | — | 15.25M | $74.74M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 5.33M | -11.1% | $31.54M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 2.84M | 0.0% | $16.81M | 0.0% | Held | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 2.14M | +18.3% | $12.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 2.14M | +18.3% | $12.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.03M | -5.5% | $6.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.03M | -5.5% | $6.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 401.40K | -31.3% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 292.37K | -82.7% | $1.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Marshall Wace ✦ | 292.37K | -82.7% | $1.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 263.36K | +36.2% | $1.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 263.36K | +36.2% | $1.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 140.92K | -56.8% | $834,229 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 81.41K | -11.6% | $481,953 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Millennium Management ✦ | 72.66K | -79.1% | $430,118 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 64.79K | -76.8% | $383,563 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 64.79K | -76.8% | $383,563 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 64.79K | -76.8% | $383,563 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 5.64K | Nuevo | $33,377 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Citadel Advisors | $33,377 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 216 tenedores, 155.62M acciones, $854.15M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.